trending Market Intelligence /marketintelligence/en/news-insights/trending/aVfAw-6Pe9ucmYg2BiXp9g2 content esgSubNav
In This List

Collegium Pharmaceutical appoints director

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Collegium Pharmaceutical appoints director

Collegium Pharmaceutical Inc. appointed Gwen Melincoff as a class III director, effective Aug. 9, with an initial term expiring at the next annual meeting of shareholders in 2018.

Melincoff is currently managing director at Gemini Advisors LLC and an adviser to Phase 1 Ventures and Verge Genomics.